In re Delcath Systems, Inc. Securities Litigation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• holding that disclosing a 7% mortality rate from the treatment group but not disclosing that there were zero deaths from the control group mislead investors about the safety of the tested medical device
• holding that disclosing a 7% mortality rate from the treatment group but not disclosing that there were zero deaths from the control group mislead investors about the safety of the tested medical device
• FDA approval statements made on conference calls and in press releases not actionable under PSLRA safe harbor because of publicly filed docs that contradicted plaintiff’s allegations
• alleged omissions were not actionable where public “[d]ocu-ments submitted by Defendants ... contradicted] the Complaint and show[ed] that the Company did disclose” the information allegedly omitted
• \Pharmaceutical companies need not disclose 'isolated reports of illnesses suffered by users.' \

Source: CourtListener parenthetical corpus (CC0).

Cited by

13 cases in this archive cite this case.

• AG Funds, L.P. v. Sanofi
  S.D. New York· 2015-01-28· cited 71×
• Lopez v. Ctpartners Executive Search Inc.
  S.D. New York· 2016-03-29· cited 50×
• Levy v. Maggiore
  E.D. New York· 2014-09-29· cited 23×
• Gregory v. Pronai Therapeutics Inc.
  S.D. Illinois· 2018-03-13· cited 23×
• Okla. Firefighters Pension & Ret. Sys. v. Xerox Corp.
  S.D. Illinois· 2018-03-20· cited 23×
• In re Aratana Therapeutics Inc. Sec. Litig.
  S.D. Illinois· 2018-06-11· cited 23×
• Gillis v. QRX Pharma Ltd.
  S.D. New York· 2016-07-06· cited 20×
• Nguyen v. New Link Genetics Corp.
  S.D. Illinois· 2018-03-29· cited 15×
• In re Barrick Gold Corp.
  S.D. Illinois· 2018-09-20· cited 11×
• Wilbush v. Ambac Financial Group, Inc.
  S.D. New York· 2017-09-05· cited 7×
• In re Neurotrope, Inc. Sec. Litig.
  S.D. Illinois· 2018-06-04· cited 3×
• Emerson v. Genocea Biosciences, Inc.
  District of Columbia· 2018-12-06· cited 3×
• In re Stemline Therapeutics, Inc. Sec. Litig.
  S.D. Illinois· 2018-03-15· cited 2×

Cites

20 cases in this archive are cited by this case.

• Ashcroft v. Iqbal
  Supreme Court· 2009-05-18· cited 149,772×
• Bell Atlantic Corp. v. Twombly
  Supreme Court· 2007-05-21· cited 146,720×
• Tellabs, Inc. v. Makor Issues & Rights, Ltd.
  Supreme Court· 2007-06-21· cited 6,044×
• ATSI Communications, Inc. v. Shaar Fund, Ltd.
  Second Circuit· 2007-07-11· cited 2,369×
• Dura Pharmaceuticals, Inc. v. Broudo
  Supreme Court· 2005-04-19· cited 2,236×
• Ruotolo v. City of New York
  Second Circuit· 2008-02-06· cited 1,344×
• Matrixx Initiatives, Inc. v. Siracusano
  Supreme Court· 2011-03-22· cited 1,056×
• Novak v. Kasaks
  Second Circuit· 2000-06-21· cited 686×
• ECA, Local 134 IBEW Joint Pension Trust of Chicago v. JP Morgan Chase Co.
  Second Circuit· 2009-01-21· cited 674×
• Rombach v. Chang
  Second Circuit· 2004-01-20· cited 523×
• Teamsters Local 445 Freight Division Pension Fund v. Dynex Capital Inc.
  Second Circuit· 2008-06-26· cited 323×
• Kleinman v. Elan Corp., plc
  Second Circuit· 2013-02-01· cited 278×
• Ilya Boguslavsky v. Martin H. Kaplan and Gusrae, Kaplan & Bruno, Paul T. Russo
  Second Circuit· 1998-10-09· cited 253×
• Anschutz Corp. v. Merrill Lynch & Co.
  Second Circuit· 2012-08-14· cited 225×
• Halperin v. eBanker USA.COM, Inc.
  Second Circuit· 2002-07-09· cited 174×
• City of Philadelphia v. Fleming Companies, Inc.
  Tenth Circuit· 2001-09-07· cited 151×
• Acticon AG v. China North East Petroleum Holdings Ltd.
  Second Circuit· 2012-08-01· cited 63×
• Unnamed case
  Second Circuit· 1998-07-13· cited 50×
• In Re AstraZeneca Securities Litigation
  S.D. New York· 2008-06-03· cited 44×
• In Re Pfizer Inc. Securities Litigation
  S.D. New York· 2008-07-01· cited 30×